Pfizer Inc.: FDA Advisory Committee Votes in Support of Appr

The positive vote is based on compelling scientific evidence presented, including Phase 3 efficacy and safety data in pregnant individuals and their infants FDA decision expected in August

Related Keywords

United States , Canada , Langley , British Columbia , Japan , Gewinn Nur , Annaliesa Anderson , Youtube , Lancet Glob Health , European Medicines Agency , Health Canada , Vaccine Research , Centers For Disease , Drug Administration , Pfizer , Pfizer Inc , National Institutes Of Health , Exchange Commission , Linkedin , Advisory Committee On Immunization Practices , Ministry Of Health , Committee For Medicinal Products Human Use , Products Advisory Committee , Related Biological Products Advisory Committee , Senior Vice President , Chief Scientific Officer , Immunization Study , New England Journal , Prescription Drug User Fee Act , Immunization Practices , Marketing Authorization Application , Medicinal Products , Human Use , Pfizer Japan , Pfizer Canada , National Institutes , Breakthroughs That Change Patient Lives , Pfizer News , Annual Report , Looking Information , Factors That May Affect Future , Disease Control , Respiratory Syncytial Virus Infection , Updated December , Older Adults , High Risk , Accessed November , Lancet Glob , First Quarter , Teleconference Presentation , Advisory , Committee , Votes , Support , Approval , Vaccine , Candidate , Help , Prevent , Infants , Through , Maternal , Immunization ,